-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Meeting News
-
Plenary 2 Explores Definitions, Treatment Modalities for Oligometastatic Disease
During the session, experts from multiple disciplines offered a variety of perspectives and insights for determining the best approach to the oligo paradigm.
-
IASLC’s Early Detection and Screening Committee Works to Raise Awareness of Air Pollution Risks
Members of the committee’s Environmental Working Group discussed the impetus for taking a position on air pollution and opportunities to learn the latest science on the subject during WCLC 2022.
-
Final Lectureship Award Winners Will Explore Evolutions in Thoracic Oncology
On Tuesday, August 9, three honorees will present state-of-the-art lectures on pathology, nursing and allied health, and staging.
-
Mini Oral Session Examines Research Surrounding Patient Advocacy Issues
Presenters will share data that offers insights into improving informed consent documents, patient communication preferences, testing novel interventions for lung cancer survivorship, and more.
-
To Make Immunotherapy More Effective in Lung Cancer, Consider the Tumor Microenvironment
During an oral abstract session on Monday afternoon, four researchers will review data that suggest transforming the tumor microenvironment to an immunomodulatory state may have a major influence on cancer outcomes.
-
Oral Abstract Presentations to Focus on the Application of Multidisciplinary Care
On Monday, August 8, four researchers will share data showing the benefits of multidisciplinary care in lung cancer, including how it can be applied in geriatric oncology to improve care for an increasingly aging population.
-
Vienna’s Museums and Historical Sites Range from Cultural to Quirky
With famous historical residents from Mozart to Freud, there’s no shortage of museums and historical sites to explore. Keep reading for recommendations from local WCLC attendees to help plan your stay in the City of Music.
-
mRNA Cancer Vaccines Show Early Clinical Promise
At Sunday’s Opening Plenary, pioneering researcher Christoph Huber shared data that gives clinicians and patients reason to hope.
-
Researchers Present Significant Trial Results During WCLC 2022
On Sunday, nine abstract presentations offered a look at data from NELSON, CodeBreaK, and more. Keep reading for part 1 of our coverage and stay tuned for part 2 in future editions.
-
As E-Cig Debate Continues, Evidence Shows They May Benefit Some Smokers
For a subset of people who had not planned to quit combustible cigarettes, real-world data show that e-cigarettes helped them to do just that.